HDAC inhibitor SNDX-275
Term · Oncology and biomedicine · MLC-T-ONC-003740
A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. Also called entinostat and SNDX-275.
| Identifier | MLC-T-ONC-003740 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | entinostat; SNDX-275 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003740",
"term": "HDAC inhibitor SNDX-275",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. Also called entinostat and SNDX-275.",
"synonyms": [
"entinostat",
"SNDX-275"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/hdac-inhibitor-sndx-275/"
}
Record 8,297 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.